Indication
Esophageal Varices
2 clinical trials
3 products
Product
belapectinClinical trial
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH CirrhosisStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Product
PlaceboClinical trial
Comparison of 24-hours Versus 72-hours of Octreotide Infusion Along With Endoscopic Therapy in Preventing Early Rebleed From Esophageal Varices: a Multi-center, Randomized Clinical StudyStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Octreotide